Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia.
Albasanz-Puig A, Durà-Miralles X, Laporte-Amargós J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Pallarès N, Bergas A, Carratalà J, Gudiol C, On Behalf Of The Ironic Study Group. Albasanz-Puig A, et al. Microorganisms. 2022 Mar 29;10(4):733. doi: 10.3390/microorganisms10040733. Microorganisms. 2022. PMID: 35456784 Free PMC article.
Posaconazole salvage therapy: The Posifi study.
Fortun J, Gioia F, Cardozo C, Gudiol C, Diago E, José Castón J, Muñoz P, López J, Puerta-Alcalde P, Enzenhofer M, Ramos A, Frutos A, Machado M, Garcia-Vidal C, Parody R, Martín-Dávila P. Fortun J, et al. Mycoses. 2019 Jun;62(6):526-533. doi: 10.1111/myc.12911. Epub 2019 Apr 3. Mycoses. 2019. PMID: 30864238
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study.
Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, García E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, Maestro de la Calle G, Manzur A, Marin JI, Márquez-Gómez I, Martín-Dávila P, Mikulska M, Montejo JM, Montero M, Morales HMP, Morales I, Novo A, Oltolini C, Peghin M, Del Pozo JL, Puerta-Alcalde P, Ruiz-Camps I, Sipahi OR, Tilley R, Yáñez L, Gomes MZR, Carratalà J; IRONIC study group. Albasanz-Puig A, et al. BMJ Open. 2019 May 24;9(5):e025744. doi: 10.1136/bmjopen-2018-025744. BMJ Open. 2019. PMID: 31129580 Free PMC article.
Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection.
Viasus D, Puerta-Alcalde P, Cardozo C, Suárez-Lledó M, Rodríguez-Núñez O, Morata L, Fehér C, Marco F, Chumbita M, Moreno-García E, Fernández-Avilés F, Gutiérrez-Garcia G, Martínez JA, Mensa J, Rovira M, Esteve J, Soriano A, Garcia-Vidal C. Viasus D, et al. Clin Microbiol Infect. 2020 Mar;26(3):345-350. doi: 10.1016/j.cmi.2019.07.002. Epub 2019 Jul 8. Clin Microbiol Infect. 2020. PMID: 31295551 Free article.
Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance.
Martinez-Nadal G, Puerta-Alcalde P, Gudiol C, Cardozo C, Albasanz-Puig A, Marco F, Laporte-Amargós J, Moreno-García E, Domingo-Doménech E, Chumbita M, Martínez JA, Soriano A, Carratalà J, Garcia-Vidal C. Martinez-Nadal G, et al. Clin Infect Dis. 2020 Mar 3;70(6):1068-1074. doi: 10.1093/cid/ciz319. Clin Infect Dis. 2020. PMID: 31321410
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia.
Cardozo C, Cuervo G, Salavert M, Merino P, Gioia F, Fernández-Ruiz M, López-Cortés LE, Escolá-Vergé L, Montejo M, Muñoz P, Aguilar-Guisado M, Puerta-Alcalde P, Tasias M, Ruiz-Gaitán A, González F, Puig-Asensio M, Vena A, Marco F, Pemán J, Fortún J, Aguado JM, Almirante B, Soriano A, Carratalá J, Garcia-Vidal C; GEMICOMED (SEIMC) and the Spanish CANDI-Bundle Group. Cardozo C, et al. J Antimicrob Chemother. 2020 Mar 1;75(3):730-737. doi: 10.1093/jac/dkz491. J Antimicrob Chemother. 2020. PMID: 31819991
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C, Albasanz-Puig A, Laporte-Amargós J, Pallarès N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Paz Morales H, Brunel AS, García E, Isler B, Kern WV, Morales I, Maestro-de la Calle G, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J; IRONIC Study Group. Gudiol C, et al. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02494-19. doi: 10.1128/AAC.02494-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32015035 Free PMC article.
Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts.
Bassetti M, Vena A, Meroi M, Cardozo C, Cuervo G, Giacobbe DR, Salavert M, Merino P, Gioia F, Fernández-Ruiz M, López-Cortés LE, Almirante B, Escolà-Vergé L, Montejo M, Aguilar-Guisado M, Puerta-Alcalde P, Tasias M, Ruiz-Gaitán A, González F, Puig-Asensio M, Marco F, Pemán J, Fortún J, Aguado JM, Soriano A, Carratalá J, Garcia-Vidal C, Valerio M, Sartor A, Bouza E, Muñoz P. Bassetti M, et al. Crit Care. 2020 Mar 26;24(1):117. doi: 10.1186/s13054-020-2793-y. Crit Care. 2020. PMID: 32216822 Free PMC article.
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).
Laporte-Amargos J, Gudiol C, Arnan M, Puerta-Alcalde P, Carmona-Torre F, Huguet M, Albasanz-Puig A, Parody R, Garcia-Vidal C, Del Pozo JL, Batlle M, Tebé C, Rigo-Bonnin R, Muñoz C, Padullés A, Tubau F, Videla S, Sureda A, Carratalà J. Laporte-Amargos J, et al. Trials. 2020 May 18;21(1):412. doi: 10.1186/s13063-020-04323-0. Trials. 2020. PMID: 32423462 Free PMC article.
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).
Albasanz-Puig A, Gudiol C, Puerta-Alcalde P, Ayaz CM, Machado M, Herrera F, Martín-Dávila P, Laporte-Amargós J, Cardozo C, Akova M, Álvarez-Uría A, Torres D, Fortún J, García-Vidal C, Muñoz P, Bergas A, Pomares H, Mercadal S, Durà-Miralles X, García-Lerma E, Pallarès N, Carratalà J. Albasanz-Puig A, et al. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0004521. doi: 10.1128/AAC.00045-21. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 33972253 Free PMC article.
93 results